Objectives-To examine the intended meaning of words used by patients to describe arthritic symptoms, and to distinguish between different patient groups on the basis of these words.
Methods-A Joint Symptom Questionnaire, developed to resemble the McGill Pain Questionnaire, was given to health professionals (n = 50) and patients with rheumatoid arthritis (RA) (n = 100), fibromyalgia (FM) (n = 50), ankylosing spondylitis (AS) (n = 50), and osteoarthritis (OA) (n = 50). Respondents were invited to define each word by selecting an appropriate heading. Comparison of patient groups was based on the selection ofwords they chose to describe their joint symptoms.
Results-Between health professionals and patients there were no semantic differences in the words given. Patients with FM chose more words to describe their symptoms than the other patient groups (RA median nine words; AS nine words; OA 10 words; FM 12 Patients were handed the questionnaire and were asked to work through the list and arrange each of the words under one of the eight category headings given. In addition, patients were asked to underline any word which they felt described their joint symptoms. The patients took the questionnaire away with them, completed it elsewhere, and returned it in a stamped addressed envelope provided.
ANALYSES OF FINDINGS
The effect of age and gender on descriptor choice may confound any attempt to discriminate between disease groups, therefore the percentage of respondents selecting each descriptor was compared between the sexes and between two age groups using the median age as cut off.
To examine the ability of the descriptors to discriminate between disease groups, logistic regression was performed using the disease group as the dependent variable, and the descriptors as independent variables. Separate logistic regressions were carried out for rheumatoid arthritis against each of the other disease groups. For each patient the following of this study. It does seem therefore that, in a forced choice situation, patients with different diseases will select an overlapping but distinctly separate spectrum of descriptors to describe their rheumatic symptoms.
In contrast with the discrimination achieved between RA, FM, and AS, OA and RA were difficult to separate using this questionnaire. Charter et al'4 also encountered this difficulty using the MPQ, with which a similar word choice for both patient groups was found. Hazes et all5 found no difference between OA and RA in terms of duration or severity of early morning stiffness. Published studies would, therefore, seem to show that patients with RA and those with OA are difficult to separate on a purely symptomatic basis. Perhaps the addition of the dimension of intensity would provide better separation between these groups.
In summary, it is important to acknowledge that this is not a diagnostic test for different rheumatic diseases, and that further development of the quetionnaire is required before it can be used in a manner similar to the MPQ. The use of this questionnaire in different disease groups suggested that a clear distinction can be made between rheumatoid arthritis, fibromyalgia and ankylosing spondylitis on symptoms alone. If further information on the site and intensity of the symptoms could be included, this might further aid distinction between the patient groups.
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